The attachment lowers the infrastructure barrier
ALLocate adds a motorized stage and AI pipeline to a conventional microscope rather than requiring a costly whole-slide scanner. The system first selects useful regions, then detects and classifies cells before producing a slide-level screening result.
Independent multi-institutional cohorts and testing on physical glass slides make the result more relevant than a digital-only benchmark, particularly for settings with limited specialist access.
A screening result is not the final diagnosis
The reported 88 percent slide-level accuracy is promising and leaves meaningful room for error. Real deployment must define which cases are missed, how slide preparation and patient populations affect performance, and when the system must defer.
The safe value proposition is expanded screening and triage with specialist confirmation, not the removal of pathology expertise from the decision.
Go to the source
Read the evidence behind this analysis. External links open in a new tab.
Nature Communications — AI-powered self-driving microscope for acute leukemia detection


